Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2009)
Dr Reddys Laboratories (RDY) posted quarterly Other Accumulated Expenses of $168.0 million for Q4 2009, up 0.6% on a QoQ basis from $167.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2009) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Other Accumulated Expenses for 1 consecutive years, with $168.0 million the latest figure, recorded in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 168.00 Mn |
| Sep 30, 2009 | 167.00 Mn |
| Jun 30, 2009 | 176.00 Mn |